BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28333413)

  • 21. Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia.
    Kobayashi R; Tawa A; Hanada R; Horibe K; Tsuchida M; Tsukimoto I;
    Pediatr Blood Cancer; 2007 Apr; 48(4):393-8. PubMed ID: 16550530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of a fludarabine and melphalan combination-based reduced toxicity conditioning with myeloablative conditioning by radiation and/or busulfan in acute myeloid leukemia in Japanese children and adolescents.
    Ishida H; Adachi S; Hasegawa D; Okamoto Y; Goto H; Inagaki J; Inoue M; Koh K; Yabe H; Kawa K; Kato K; Atsuta Y; Kudo K
    Pediatr Blood Cancer; 2015 May; 62(5):883-9. PubMed ID: 25545836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and prognostic significance of c-KIT mutations in core binding factor acute myeloid leukemia: a comprehensive large-scale study from a single Chinese center.
    Qin YZ; Zhu HH; Jiang Q; Jiang H; Zhang LP; Xu LP; Wang Y; Liu YR; Lai YY; Shi HX; Jiang B; Huang XJ
    Leuk Res; 2014 Dec; 38(12):1435-40. PubMed ID: 25449688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of health in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study.
    Molgaard-Hansen L; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros-Svennilson J; Nysom K; Hasle H;
    Pediatr Blood Cancer; 2011 Dec; 57(7):1222-9. PubMed ID: 22095929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse.
    Solh M; DeFor TE; Weisdorf DJ; Kaufman DS
    Biol Blood Marrow Transplant; 2012 Jan; 18(1):106-12. PubMed ID: 21703975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous stem cell transplantation in acute myeloid leukemia. Factors influencing outcome. A 13 year single institution experience.
    Martins C; Lacerda JF; Lourenço F; Carmo JA; Lacerda JM
    Acta Med Port; 2005; 18(5):329-37. PubMed ID: 16611537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extramedullary relapse of acute leukemia after haploidentical hematopoietic stem cell transplantation: incidence, risk factors, treatment, and clinical outcomes.
    Mo XD; Kong J; Zhao T; Xu LP; Zhang XH; Liu DH; Wang Y; Chen H; Yan CH; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
    Biol Blood Marrow Transplant; 2014 Dec; 20(12):2023-8. PubMed ID: 25196855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics and treatment of acute myeloid neoplasms with cutaneous involvement in infants up to 6 months of age: A retrospective study.
    Renaud J; Goemans BF; Locatelli F; Pigazzi M; Redmond S; Kuehni CE; Destaillats A; Alonzo TA; Gerbing RB; Gamis A; Aplenc R; Renella R; Cooper T; Ceppi F
    Pediatr Blood Cancer; 2024 Jul; 71(7):e31006. PubMed ID: 38616361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperleucocytosis in paediatric acute myeloid leukaemia - the challenge of white blood cell counts above 200 × 10
    Zeller B; Glosli H; Forestier E; Ha SY; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Hasle H; Abrahamsson J;
    Br J Haematol; 2017 Aug; 178(3):448-456. PubMed ID: 28542715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome of childhood acute myeloid leukemia in a developing country: experience from a children's hospital in China.
    Xu XJ; Tang YM; Song H; Yang SL; Shi SW; Wei J
    Leuk Lymphoma; 2010 Dec; 51(12):2262-9. PubMed ID: 20929322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pubertal development and fertility in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study.
    Molgaard-Hansen L; Skou AS; Juul A; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros J; Nysom K; Hasle H;
    Pediatr Blood Cancer; 2013 Dec; 60(12):1988-95. PubMed ID: 24038890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation.
    Devillier R; Harbi S; Fürst S; Crocchiolo R; El-Cheikh J; Castagna L; Etienne A; Calmels B; Lemarie C; Prebet T; Granata A; Charbonnier A; Rey J; Chabannon C; Faucher C; Vey N; Blaise D
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1560-5. PubMed ID: 24933658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The utility of performing the initial lumbar puncture on day 8 in remission induction therapy for childhood acute lymphoblastic leukemia: TCCSG L99-15 study.
    Hasegawa D; Manabe A; Ohara A; Kikuchi A; Koh K; Kiyokawa N; Fukushima T; Ishida Y; Saito T; Hanada R; Tsuchida M;
    Pediatr Blood Cancer; 2012 Jan; 58(1):23-30. PubMed ID: 21254378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of children treated for relapsed acute myeloid leukemia in Central America.
    Marjerrison S; Antillon F; Bonilla M; Fu L; Martinez R; Valverde P; Vasquez R; Howard SC; Ribeiro RC; Sung L
    Pediatr Blood Cancer; 2014 Jul; 61(7):1222-6. PubMed ID: 24443303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study Group.
    Kinoshita A; Miyachi H; Matsushita H; Yabe M; Taki T; Watanabe T; Saito AM; Tomizawa D; Taga T; Takahashi H; Matsuo H; Kodama K; Ohki K; Hayashi Y; Tawa A; Horibe K; Adachi S
    Br J Haematol; 2014 Oct; 167(1):80-6. PubMed ID: 25039450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutis.
    Michel G; Boulad F; Small TN; Black P; Heller G; Castro-Malaspina H; Childs BH; Gillio AP; Papadopoulos EB; Young JW; Kernan NA; O'Reilly RJ
    Bone Marrow Transplant; 1997 Jul; 20(2):107-12. PubMed ID: 9244412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tailored central nervous system-directed treatment strategy for isolated CNS recurrence of adult acute myeloid leukemia.
    Zheng C; Liu X; Zhu W; Cai X; Wu J; Sun Z
    Hematology; 2014 Jun; 19(4):208-12. PubMed ID: 24074528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allogeneic bone marrow transplantation in first remission for children with very high-risk acute lymphoblastic leukemia: a retrospective case-control study in the Nordic countries. Nordic Society for Pediatric Hematology and Oncology (NOPHO).
    Saarinen UM; Mellander L; Nysom K; Ringden O; Schroeder H; Glomstein A; Gustafsson G
    Bone Marrow Transplant; 1996 Mar; 17(3):357-63. PubMed ID: 8704687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA Methylation Adds Prognostic Value to Minimal Residual Disease Status in Pediatric T-Cell Acute Lymphoblastic Leukemia.
    Borssén M; Haider Z; Landfors M; Norén-Nyström U; Schmiegelow K; Åsberg AE; Kanerva J; Madsen HO; Marquart H; Heyman M; Hultdin M; Roos G; Forestier E; Degerman S
    Pediatr Blood Cancer; 2016 Jul; 63(7):1185-92. PubMed ID: 26928953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.